ABSCF (AB Science) Other Stockholders Equity: $-348.62 Mil (As of Dec. 2025)


ABSCF AB Science ABSCF
58 GF Score
Price $1.12
GF Value $2.18
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is AB Science Other Stockholders Equity?

AB Science ABSCF 58 Other Stockholders Equity is $-348.62 Mil as of Dec. 2025. GuruFocus rates ABSCF with a GF Score™ of 58/100 and a GF Value™ of $2.18 (Possible Value Trap). The stock has 11 warning signs investors should review.

AB Science's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $-348.62 Mil.

AB Science's quarterly Other Stockholders Equity declined from Dec. 2024 ($-309.79 Mil) to Jun. 2025 ($-347.09 Mil) and declined from Jun. 2025 ($-347.09 Mil) to Dec. 2025 ($-348.62 Mil).

AB Science's annual Other Stockholders Equity declined from Dec. 2023 ($-303.38 Mil) to Dec. 2024 ($-309.79 Mil) and declined from Dec. 2024 ($-309.79 Mil) to Dec. 2025 ($-348.62 Mil).

AB Science Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for AB Science's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AB Science Other Stockholders Equity Chart

AB Science Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -291.06 -286.09 -303.38 -309.79 -348.62

AB Science Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -303.38 -314.04 -309.79 -347.09 -348.62
ABSCF
58GF Score
AB Science ABSCF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AB Science Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-348.62 Mil mean?
AB Science (ABSCF) has a Other Stockholders Equity of $-348.62 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on AB Science and its competitors.
Is AB Science's Other Stockholders Equity too high?
AB Science's current Other Stockholders Equity is $-348.62 Mil. Overall, AB Science has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AB Science's Other Stockholders Equity compare to ZTS and UTHR?
AB Science's Other Stockholders Equity of $-348.62 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on AB Science and its competitors. AB Science's current Other Stockholders Equity is $-348.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AB Science stock overvalued right now?
Based on GuruFocus' analysis, AB Science (ABSCF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.18, compared to a current price of $1.12 — trading 48.6% below its estimated fair value. The current Other Stockholders Equity is $-348.62 Mil. AB Science's overall GF Score™ is 58/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For AB Science (ABSCF), the current Other Stockholders Equity is $-348.62 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AB Science (ABSCF) Overvalued in 2026?

Based on GuruFocus' analysis, AB Science stock appears to be undervalued. The current stock price of $1.12 is trading 48.6% below its estimated GF Value™ of $2.18. GuruFocus considers AB Science to be Possible Value Trap.

Key valuation signals for ABSCF:

  • Other Stockholders Equity: $-348.62 Mil
  • GF Value™: $2.18 vs. price of $1.12 (48.6% below fair value)
  • GF Score™: 58/100 with 11 warning signs

No single metric tells the full story. See the ABSCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AB Science Business Description

Other Exchanges 0Q77:UKAB:FranceA8D:Germany
Address 3, Avenue George V, Paris, FRA, 75008
AB Science is a clinical-stage pharmaceutical company that has developed a diversified portfolio of medicines targeting unmet medical needs, based on two platforms. Masitinib platform: It is based on masitinib, a selective protein kinase inhibitor in development for neurodegenerative diseases, oncology, & inflammatory diseases. It has the clinical development of masitinib in neurodegenerative diseases (specifically Alzheimer's disease, amyotrophic lateral sclerosis, & progressive forms of multiple sclerosis). ALDH/Microtubule Platform: It is a portfolio of synthetic agents that target cancer cells by destabilising microtubules, which are essential for cell division & cancer stem cells, by inhibiting enzymes that are essential for maintaining their physiological state & survival.
58GF Score

Get the complete analysis for ABSCF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.12
Price
$2.18
GF Value